Vicente A Torres (Pilar Sanchez-Gomez, Pilar Sánchez-Gómez)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 22

Top Topics

Advanced Non Small Cell Lung Cancer

Tyrosine Kinase

Cancer Stem Cells

Top Venues

Cell adhesion & migration

Scientific reports

This page only lists publications with an associated author ORCID identifier.

Publications

Andrea Álvarez-Vázquez, Laura San-Segundo, Pilar Cerveró-García, Raquel Flores Hernández, Claudia Ollauri-Ibáñez, Berta Segura-Collar, Christopher G Hubert, Gillian Morrison, Steven M Pollard, Justin D Lathia, Vicente A Torres, Arantxa Tabernero
EGFR amplification and EGFRvIII predict and participate in TAT-Cx43266-283 antitumor response in preclinical glioblastoma models. Neuro-oncology 26 (7) (2024)
Olaya de Dios, M Angeles Ramírez-González, Irene Gómez-Soria, Berta Segura-Collar, Juliana Manosalva, Diego Megías, Carlos E De Andrea, Leticia Fernández-Rubio, Aurelio Hernández-Laín, Juan M Sepúlveda-Sánchez, Maria E Rodríguez-Ruiz, Ángel Pérez-Núñez, Derek A Wainwright, Ricardo Gargini, Vicente A Torres
NKG2C/ KLRC2 tumor cell expression enhances immunotherapeutic efficacy against glioblastoma. Journal for immunotherapy of cancer 12 (8) (2024)
Andrea Álvarez-Vázquez, Laura San-Segundo, Pilar Cerveró-García, Raquel Flores Hernández, Claudia Ollauri-Ibáñez, Berta Segura-Collar, Christopher G Hubert, Gillian Morrison, Steven M Pollard, Justin D Lathia, Vicente A Torres, Arantxa Tabernero
EGFR amplification and EGFRvIII predict and participate in TAT-Cx43266-283 antitumor response in preclinical glioblastoma models. Neuro-oncology 26 (7) (2024)
Andrea Álvarez-Vázquez, Laura San-Segundo, Pilar Cerveró-García, Raquel Flores Hernández, Claudia Ollauri-Ibáñez, Berta Segura-Collar, C G Hubert, Gillian Morrison, Steven M Pollard, Justin D Lathia, Vicente A Torres, Arantxa Tabernero
EGFR amplification and EGFRvIII predict and participate in TAT-Cx43266-283 antitumor response in preclinical glioblastoma models. Neuro-oncology (2024)
Andrea Álvarez-Vázquez, Laura San-Segundo, Pilar Cerveró-García, Raquel Flores Hernández, Claudia Ollauri-Ibáñez, Berta Segura-Collar, Christopher G Hubert, Gillian Morrison, Steven M Pollard, Justin D Lathia, Vicente A Torres, Arantxa Tabernero
EGFR amplification and EGFRvIII predict and participate in TAT-Cx43266-283 antitumor response in preclinical glioblastoma models. Neuro-oncology 26 (7) (2024)
Andrea Álvarez-Vázquez, Laura San-Segundo, Pilar Cerveró-García, Raquel Flores Hernández, Claudia Ollauri-Ibáñez, Berta Segura-Collar, Christopher G Hubert, Gillian Morrison, Steven M Pollard, Justin D Lathia, Vicente A Torres, Arantxa Tabernero
EGFR amplification and EGFRvIII predict and participate in TAT-Cx43266-283 antitumor response in preclinical glioblastoma models. Neuro-oncology 26 (7) (2024)
Olaya de Dios, M Angeles Ramírez-González, Irene Gómez-Soria, Berta Segura-Collar, Juliana Manosalva, Diego Megías, Carlos E De Andrea, Leticia Fernández-Rubio, Aurelio Hernández-Laín, Juan M Sepúlveda-Sánchez, Maria E Rodríguez-Ruiz, Ángel Pérez-Núñez, Derek A Wainwright, Ricardo Gargini, Vicente A Torres
NKG2C/ KLRC2 tumor cell expression enhances immunotherapeutic efficacy against glioblastoma. Journal for immunotherapy of cancer 12 (8) (2024)
Berta Segura-Collar, Juan Jiménez-Sanchez, Ricardo Gargini, Miodrag Dragoj, Juan Manuel Sepúlveda Sánchez, Milica Pesic, María A Ramírez, Luis E Ayala-Hernández, Vicente A Torres, Victor M Pérez-García
On optimal temozolomide scheduling for slowly growing glioblastomas. Neuro-oncology advances 4 (1) (2022)
Ricardo Gargini, Berta Segura-Collar, María Garranzo-Asensio, Rafael Hortigüela, Patricia Iglesias-Hernández, Daniel Lobato-Alonso, Miguel Moreno-Raja, Santiago Esteban-Martin, Juan M Sepúlveda-Sánchez, Laura Nevola, Vicente A Torres
IDP-410: a Novel Therapeutic Peptide that Alters N-MYC Stability and Reduces Angiogenesis and Tumor Progression in Glioblastomas. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 19 (1) (2022)
Andrea A Villanueva, Pilar Sanchez-Gomez, Ernesto Muñoz-Palma, Sofía Puvogel, Bárbara S Casas, Cecilia Arriagada, Isaac Peña-Villalobos, Pablo Lois, Manuel Ramírez, Fabiana Lubieniecki, Fernando Casco Claro, Iván Gallegos, Javier García-Castro, Vicente A Torres, Verónica Palma
The Netrin-1-Neogenin-1 signaling axis controls neuroblastoma cell migration via integrin-β1 and focal adhesion kinase activation. Cell adhesion & migration 15 (1) (2022)
Ana Virginia Sánchez-Sánchez, Antonio García-España, Vicente A Torres, Jaime Font de Mora, Marián Merino, José Luis Mullor
The Embryonic Key Pluripotent Factor NANOG Mediates Glioblastoma Cell Migration via the SDF1/CXCR4 Pathway. International journal of molecular sciences 22 (19) (2021)
Ximena Vásquez, Vicente A Torres, Verónica Palma
Netrin-1 in Glioblastoma Neovascularization: The New Partner in Crime? International journal of molecular sciences 22 (15) (2021)
Ricardo Gargini, Berta Segura-Collar, Beatriz Herránz, Vega García-Escudero, Andrés Romero-Bravo, Felipe J Núñez, Daniel García-Pérez, Jacqueline Gutiérrez-Guamán, Angel Ayuso-Sacido, Joan Seoane, Angel Pérez-Nuñez, Juan M Sepúlveda-Sánchez, Aurelio Hernández-Laín, Maria Graciela Castro, Ramon Garcia-Escudero, Jesús Avila, Vicente A Torres
The IDH-TAU-EGFR triad defines the neovascular landscape of diffuse gliomas. Science translational medicine 12 (527) (2021)
Berta Segura-Collar, María Garranzo-Asensio, Beatriz Herránz, Esther Hernandez-SanMiguel, Teresa Cejalvo, Bárbara S Casas, Ander Matheu, Ángel Pérez-Núñez, Juan Manuel Sepúlveda Sánchez, Aurelio Hernández-Laín, Verónica Palma, Ricardo Gargini, Vicente A Torres
Tumor-Derived Pericytes Driven by EGFR Mutations Govern the Vascular and Immune Microenvironment of Gliomas. Cancer research 81 (8) (2021)
Berta Segura-Collar, Ricardo Gargini, Elena Tovar-Ambel, Esther Hernandez-SanMiguel, Carolina Epifano, Ignacio Pérez de Castro, Aurelio Hernández-Laín, Sergio Casas-Tintó, Vicente A Torres
The EGFR-TMEM167A-p53 Axis Defines the Aggressiveness of Gliomas. Cancers 12 (1) (2020)
Teresa Cejalvo, Ricardo Gargini, Berta Segura-Collar, Pablo Mata-Martínez, Beatriz Herranz, Diana Cantero, Yolanda Ruano, Daniel García-Pérez, Ángel Pérez-Núñez, Ana Ramos, Aurelio Hernández-Laín, María Cruz Martín-Soberón, Vicente A Torres, Juan Manuel Sepúlveda Sánchez
Immune Profiling of Gliomas Reveals a Connection with IDH1/2 Mutations, Tau Function and the Vascular Phenotype. Cancers 12 (11) (2020)
Esther Hernández-SanMiguel, Ricardo Gargini, Teresa Cejalvo, Berta Segura-Collar, Paula Núñez-Hervada, Rafael Hortigüela, Juan M Sepúlveda-Sánchez, Aurelio Hernández-Laín, Angel Pérez-Núñez, Eduardo Sanz, Vicente A Torres
Ocoxin Modulates Cancer Stem Cells and M2 Macrophage Polarization in Glioblastoma. Oxidative medicine and cellular longevity 2019 (2019)
Monika Kuciak, Christophe Mas, Isabel Borges, Vicente A Torres, Ariel Ruiz I Altaba
Chimeric NANOG repressors inhibit glioblastoma growth in vivo in a context-dependent manner. Scientific reports 9 (1) (2019)
Katia Urso, Andrés Fernández, Patricia Velasco, Javier Cotrina, Belén de Andrés, Vicente A Torres, Aurelio Hernández-Laín, Sonsoles Hortelano, Juan Miguel Redondo, Eva Cano
NFATc3 controls tumour growth by regulating proliferation and migration of human astroglioma cells. Scientific reports 9 (1) (2019)
Juan Manuel Sepúlveda Sánchez, Vicente A Torres, María Ángeles Vaz Salgado, Ricardo Gargini, Carmen Balañá
Dacomitinib: an investigational drug for the treatment of glioblastoma. Expert opinion on investigational drugs 27 (10) (2018)
Andrea A Villanueva, Sofía Puvogel, Pablo Lois, Ernesto Muñoz-Palma, Manuel Ramírez, Fabiana Lubieniecki, Fernando Casco Claro, Iván Gallegos, Javier García-Castro, Vicente A Torres, Vicente A Torres, Verónica Palma
The Netrin-4/Laminin γ1/Neogenin-1 complex mediates migration in SK-N-SH neuroblastoma cells. Cell adhesion & migration 13 (1) (2018)
Marta Portela, Berta Segura-Collar, Irene Argudo, Almudena Sáiz, Ricardo Gargini, Vicente A Torres, Sergio Casas Tintó
Oncogenic dependence of glioma cells on kish/TMEM167A regulation of vesicular trafficking. Glia 67 (2) (2018)